The Latest Advances in the Management of Atopic Dermatitis and the Role of JAK Inhibitors: Best Practices for the Pharmacist | PTCE Pharmacy Connect

Educational Objectives ·      Understand the impact of Janus kinase inhibitors for the management of atopic dermatitis (AD) ·      Examine key safety and efficacy data on new and emerging Janus kinase inhibitors utilized for the treatment of AD and select appropriate treatments Identify the role of the pharmacist in individualizing treatment for patients with AD through patient counseling and education Faculty: Svetlana Gerzenshtein, PharmD, BCPS, CSP Clinical Pharmacist Specialist Specialty Pharmacy Department University of Chicago Medical Center Chicago, Illinois Content Development Sarah Lant, PharmD Clinical Pharmacist Specialist UChicago Medicine Chicago, Illinois Svetlana Gerzenshtein, PharmD, BCPS, CSP, has no financial relationships with commercial interests to disclose. Sarah Lant, PharmD, has the following relevant financial relationship with a commercial interest to disclose: Other (faculty speaker training): Lily Learn more about your ad choices. Visit megaphone.fm/adchoices